In vitro diagnostics (IVD) are diagnostic tests practiced in an artificial environment. The overall revenue of the Asia-Pacific IVD market accounted for about $10.7 billion in 2014, and is estimated to reach $15.3 billion by 2020, registering a CAGR of 6.5% over the forecast period. To know more visit us @ http://www.apacmarket.com/top-market/apac-in-vitro-diagnostics-market

1. No. Pages : 180 Published Date: 31-Jul-2015
In Vitro Diagnostics (IVD) Asia-Pacific Market Research Report
2014-2020

2. In vitro diagnostics (IVD) are diagnostic tests practiced in an artificial
environment. The overall revenue of the Asia-Pacific IVD market
accounted for about $10.7 billion in 2014, and is estimated to reach
$15.3 billion by 2020, registering a CAGR of 6.5% over the forecast
period. Considerable increase in the number of chronic and infectious
diseases, growing awareness towards healthcare solutions and
technological advancements in healthcare industry largely supplement
the growth of this market.
However, stringent regulatory policies and reimbursements issues in
few countries limit the growth of this market. The rising demand for
technologically advanced diagnostic devices, rise in GDP and per capita
income and rise in disposable incomes facilitate a huge potential for
the IVD market in the Asia-Pacific region. The Asia-Pacific IVD market is
segmented based on technique, product type, usability, application,
end user and country.
Report Description

3. Based on technique, the market is segmented into immunoassays,
clinical chemistry, point-of-care, molecular diagnostics, hematology,
coagulation, microbiology and other clinical techniques. Point-of-care
is the highest revenue-generating segment in the overall IVD
techniques market. However, the molecular diagnostics is the fastest
growing technique in the overall IVD techniques market due to its
ability to accurately detect the primary cause of the disease.
Based on product type, the market is segmented into instruments,
reagents, data management systems and services.
Instruments segment holds the highest market share in the Asia-
Pacific IVD market followed by rapidly growing reagents segment.
Reagents are largely used in various equipment and play a key role in
the overall diagnosis process. The usability segment is classified as
disposable and reusable IVD devices.
Report Description

4. Doctors and clinicians largely prefer disposable devices to avoid
infections; generating larger revenue in comparison to reusable
devices. The application segment is categorized into infectious
diseases diabetes, cancer/oncology, cardiology, autoimmune diseases,
nephrology, drug testing, HIV/AIDS and others. Infectious diseases
was the highest revenue-generating segment in 2014 and would
continue to maintain its position throughout 2020, due to the rise in
incidences of infectious diseases.
Hospitals and laboratories, academics, point-of-care testing and
others form the end users segment in the Asia-Pacific IVD market.
Hospitals and laboratories generate the highest revenue, followed by
point-of-care. A significant rise in the number of hospitals and
laboratories across the Asia-Pacific region along with increased
awareness about developments in healthcare largely contribute to
the growth of this segment.
Report Description

5.  Extensive coverage of the Asia-Pacific IVD market including drivers,
restraints and opportunities would help professionals to better
understand the market behavior
 The projections in the report are made by analyzing the current
market trends and market potential for the period of 2014–2020
 A comprehensive analysis of the market scenario in terms of
technologies, applications, usability, product type end users and
geography helps identify the growth opportunities in the Asia-
Pacific IVD market
 Key market players within the Asia-Pacific IVD market are profiled
in the report and their strategies are analysed thoroughly, which
helps in understanding competitive outlook of this market
Key Market Benefits

6. Key Market Segments by Instruments
Techniques Immunoassays
Clinical Chemistry
Point Of Care
Microbiology
Applications Diabetes
Cancer/Oncology
Cardiology
HIV/AIDS
Product
Type
Instruments
Reagents
Data management
Services

7. IVF Market – by Geography
China
Australia
India
Japan
Other

8. Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Asia Pacific IVD Market, by Techniques
Chapter 5 Asia Pacific IVD Market, by Product Type
Chapter 6 Asia Pacific IVD Market, by Usability
Chapter 7 Asia Pacific IVD Market, by Application
Chapter 8 Asia Pacific IVD Market, by End-users
Chapter 9 Asia Pacific IVD Market, by Countries
Table of Contents

9. FOR MORE DETAILS
Visit us at :
http://www.apacmarket.com/top-market/apac-in-vitro-
diagnostics-market
Stay With Us:
TELEPHONE: +61-280 454 214 EMAIL: help@apacmarket.com